Haemophilus B Influenzae Antibodies

Understanding the Haemophilus Influenzae Type B Antibodies blood test

The Haemophilus Influenzae Type B Antibodies blood test measures IgG antibodies directed against Haemophilus Influenzae Type B (Hib), a bacterium that can cause serious invasive infections, particularly in infants and young children.

Haemophilus Influenzae Type B is most well known for causing meningitis, epiglottitis, pneumonia, and septicaemia. Routine childhood vaccination has significantly reduced the incidence of severe disease, but antibody testing remains important in specific clinical situations.

This test does not detect active infection. Instead, it evaluates whether sufficient antibody levels are present to provide protective immunity, most commonly following vaccination or in individuals with immune system concerns.

When a Haemophilus Influenzae Type B Antibodies test is recommended

This test is recommended when there is a need to assess immune protection against Haemophilus Influenzae Type B, particularly in individuals at higher risk of infection or those with uncertain vaccine response.

It is frequently used in immunology assessments, vaccine response evaluations, and investigations of recurrent or severe infections.

Testing may be appropriate if you:

• Need confirmation of immunity after Hib vaccination
• Have a weakened immune system
• Experience recurrent or severe bacterial infections
• Are undergoing immunology or immune function assessment
• Have had poor response to routine vaccinations
• Require antibody response evaluation after vaccination
• Are being assessed before or after immunosuppressive treatment
• Need reassurance regarding protective immunity

Benefits of the Haemophilus Influenzae Type B Antibodies test

• Confirms protective immunity against Hib
  Indicates whether antibody levels are sufficient.
• Assesses vaccine response
  Helps determine effectiveness of vaccination.
• Useful in immunodeficiency investigations
  Supports assessment of immune function.
• Guides revaccination decisions
  Identifies individuals who may need booster doses.
• Non-invasive assessment of immune protection
  Requires only a blood sample.
• Supports investigation of recurrent infections
  Helps explain susceptibility to bacterial illness.
• Simple blood test with no preparation required
  No fasting or lifestyle changes needed.
• Provides reassurance or clinical direction
  Clarifies immune status accurately.

How the test is carried out

We offer two convenient UK-wide testing options:

Clinic-based blood testing

• Choose your nearest UK clinic
• A healthcare professional collects a blood sample
• The sample is analysed in a certified laboratory
• Results are issued once testing is complete

Home or hotel blood collection (+£60)

• A qualified phlebotomist visits your home, workplace, or hotel
• Blood is collected at a time convenient for you
• No clinic visit required
• Available nationwide across the UK

Both options provide the same laboratory accuracy and clinical reliability.

Understanding your Haemophilus Influenzae Type B Antibodies results

Low antibody levels

Low antibody levels indicate insufficient immunity against Haemophilus Influenzae Type B. This may suggest reduced vaccine response or waning immunity.

Typical UK reference interpretation:

• Below protective threshold

Further clinical assessment or revaccination may be considered.

Adequate protective antibody levels

Adequate antibody levels indicate protective immunity against Haemophilus Influenzae Type B.

Typical UK reference interpretation:

• Protective

No further action is usually required unless clinically indicated.

Very high antibody levels

High antibody levels indicate strong immune protection, often following recent vaccination or effective immune response.

Typical UK interpretation:

• Strong immunity present

This confirms good vaccine response.